Clinical trials
Every registered trial of Thymosin Beta-4
12 studies, 2 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Very little human research on Thymosin Beta-4 has been registered.
- 12 registered studies in total.
- 2 are still enrolling people, so this is active research, not just history.
What kind of research
- 12 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 2,004 people took part in those.
How far along it is
- 5 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 1 has published results in the medical literature that anyone can read.
- The research spans 6 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.